Dr Patrizia Viola

Dr Patrizia Viola graduated from high school in the USA in 2000 and in Italy in 2001, where she focused on scientific subjects. She was enrolled in medical school in Italy from October 2001 to October 2007, when she graduated with the highest grade and honour. During the last two years of medical school, she completed a Doctor of Medicine on the relationship between cervical cancer and HPV-induced lesions. In February 2008 she became a member of the Italian equivalent of the General Medical Council (GMC). In 2021 she was awarded an MSc from Queen Mary University in molecular pathology.

From June 2009 to July 2014 Dr Viola undertook a pathology training programme as specialist register in histo/cytopathology. In July 2012 she registered with the GMC and spent two months as visiting fellow at University College London Hospital. From February 2014 to January 2016, she worked as a clinical fellow at Royal Brompton Hospital. She has been on the GMC specialist register since August 2014. From February 2016 to November 2016 Dr Viola worked as a consultant histo/cytopathologist at Whittington Health, where she was specialty lead for lung and gynaecology pathology. She joined Imperial College Healthcare NHS Trust in November 2016 as consultant histopathologist and cytopathologist. She was granted an association with the Faculty of Medicine, Imperial College London as Honorary Senior Lecturer for the Division of Cancer, Department of Surgery and Cancer. Since November 2023 she is the genomic lead for the pathology service.

Dr Viola is a principal investigator for several grants, and her research work has been presented to several international conferences. She is also author of several papers published in high impact peer-reviewed journals. Examples of her latest work is below:

A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non-small cell lung cancer.
Chen M, Copley SJ, Linton-Reid K, Viola P, Han Y, Cortellini A, Lu H, Mani A, Bahket M, Pinato DJ, Power D, Rockall AG, Aboagye EO.
Sci Rep. 2026 Mar 6. doi: 10.1038/s41598-026-42948-4. PMID: 41792401

An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [18F]FDG PET/CT radiomics.
Chen M, Copley SJ, Han Y, Arshad MA, Viola P, Linton-Reid K, Stoycheva T, Cook GJR, Landau D, Chua S, O'Connor R, Dickson J, Power D, Rockall AG, Barwick TD, Aboagye EO.
Eur J Nucl Med Mol Imaging. 2026 Apr;53(5):3195-3212. doi: 10.1007/s00259-025-07659-4. Epub 2025 Dec 12. PMID: 41381759

Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.
Taniere P, Nicholson AG, Gosney JR, Montero Fernandez MA, Bury D, Moore DA, Verghese E, Soomro I, Joseph L, Bhatt N, Viola P, Bains R, Lanctot AG, Ryan J.
J Clin Pathol. 2024 Jun 19;77(7):486-494. doi: 10.1136/jcp-2023-208890. PMID: 37258251  

Radiomics and artificial intelligence for precision medicine in lung cancer treatment.Chen M, Copley SJ, Viola P, Lu H, Aboagye EO.Semin Cancer Biol. 2023 Aug;93:97-113. doi: 10.1016/j.semcancer.2023.05.004. Epub 2023 May 19. PMID: 37211292

A novel radiogenomics biomarker for predicting treatment response and pneumotoxicity from programmed cell death protein or ligand-1 inhibition immunotherapy in NSCLC.
Chen M, Lu H, Copley SJ, Han Y, Logan A, Viola P, Cortellini A, Pinato DJ, Power D, Aboagye EO. J Thorac Oncol. 2023 Jun;18(6):718-730. doi: 10.1016/j.jtho.2023.01.089. Epub 2023 Feb 10. PMID: 36773776

Association of machine learning-based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC.
Rakaee M, Adib E, Ricciuti B, Sholl LM, Shi W, Alessi JV, Cortellini A, Fulgenzi CAM, Viola P, Pinato DJ, Hashemi S, Bahce I, Houda I, Ulas EB, Radonic T, Väyrynen JP, Richardsen E, Jamaly S, Andersen S, Donnem T, Awad MM, Kwiatkowski DJ.JAMA Oncol. 2023 Jan 1;9(1):51-60. doi: 10.1001/jamaoncol.2022.4933.
PMID: 36394839